The top after-market NASDAQ Stock Market gainers are: FSI International, EnerNOC, Dell, AVEO Pharmaceuticals, and Gulf Resources. The top after-market NASDAQ Stock Market losers are: Coldwater Creek, Celldex Therapeutics, Boston Private Financial Holdings, Novavax, and Myriad Genetics.
FSI International Inc. (FSII) stock jumped 8.28 percent to $5.23 in the after-market trading.
EnerNOC, Inc. (ENOC) stock grew 6.30 percent to $20.42 in the after-market trading.
Dell Inc. (DELL) stock grew 6.16 percent to $16.88 in the after-market trading. Profit for the first quarter was $945 million or $0.49 per share, up from $341 million or $0.17 per share last year. Adjusted earnings grew to $1.05 billion or $0.55 per share from $584 million or $0.30 per share last year. Revenue rose 1 percent to $15.02 billion, on solid growth in commercial and enterprise sectors. Analysts had expected profit of $0.43 per share on revenue of $15.40 billion.
Dell said last month it plans to invest $1 billion in the current fiscal year to deliver new solutions, build cloud capabilities and add significant numbers of new engineering, development and solutions-based sales resources in the U.S. and globally to support its enterprise solutions and services focus. Looking ahead into the second quarter, Dell said it expects mid-single digit revenue growth, which is slightly above its normal, sequential seasonal growth of 2 percent to 3 percent.
In addition, Dell said it still expects fiscal 2012 revenue to grow 5 percent to 9 percent, implying revenue of $64.56 billion to $67.02 billion, while Street predicts $64.61 billion with a revenue growth of 5.10 percent. The company increased its 2012 adjusted operating earnings growth outlook to range of 12 percent to 18 percent from previous growth forecast of 6 percent to 12 percent.
AVEO Pharmaceuticals, Inc. (AVEO) stock increased 5.26 percent to $20 in the after-market trading. The stock touched a new life-time high of $19.73 on Tuesday.
Gulf Resources, Inc. (GFRE) stock rose 5.26 percent to $4.40 in the after-market trading.
Coldwater Creek Inc. (CWTR) stock plunged 22.95 percent to $2.25 in the after-market trading. The company announced preliminary results for the first quarter of 2011, expecting a loss of $0.32 to $0.34 per share, compared to a profit of $0.03 last year. Street predicts a loss of $0.10 per share. The company expects net sales of nearly $180 million for the first quarter, reflecting a decline in comparable premium retail store sales of almost 28 percent compared to last year, while Street predicts revenue of $219.10 million.
During the first quarter, we experienced continued weak trends in traffic and sales as our merchandise offerings were not well received by our customers. We are in the process of repositioning our brand and view 2011 as a transitional year for Coldwater Creek. We look forward to seeing the results of our new design, development and merchandising initiatives as we move through the year, said Dennis Pence, Chief Executive Officer of Coldwater Creek.
In addition, Coldwater Creek said it has completed an amendment of its existing credit facility that extends the facility maturity date three years to May 16, 2016, which includes the addition and funding of a $15 million term note. The term note transaction generated net cash proceeds of $14.4 million for the company subsequent to the end of the first quarter of fiscal 2011.
Celldex Therapeutics, Inc. (CLDX) stock fell 8.51 percent to $3.55 in the after-market trading. The company said it is offering shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Celldex said the shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission on Form S-3. Jefferies & Company, Inc. is acting as the sole book-running manager for the proposed offering. Wedbush Securities Inc. is acting as co-manager for the proposed offering.
Boston Private Financial Holdings Inc. (BPFH) stock slid 4.22 percent to $6.35 in the after-market trading.
Novavax, Inc. (NVAX) stock declined 3.79 percent to $2.338 in the after-market trading.
Myriad Genetics Inc. (MYGN) stock decreased 2.52 percent to $23.56 in the after-market trading.